Skip to menu Skip to content Skip to footer

1997

Journal Article

Ocular abnormalities in chronic schizophrenia: clinical implications

Smith, D, Pantelis, C, McGrath, J, Tangas, C and Copolov, D (1997). Ocular abnormalities in chronic schizophrenia: clinical implications. Australian And New Zealand Journal of Psychiatry, 31 (2), 252-256. doi: 10.3109/00048679709073828

Ocular abnormalities in chronic schizophrenia: clinical implications

1997

Journal Article

Symptom profile and functional ability in treatment-refractory schizophrenia: Evidence for a differential impact of clozapine

Chatteron, R, Boschen, M, vanLeent, S and McGrath, J (1997). Symptom profile and functional ability in treatment-refractory schizophrenia: Evidence for a differential impact of clozapine. Schizophrenia Research, 24 (1-2), 186-186. doi: 10.1016/S0920-9964(97)82529-7

Symptom profile and functional ability in treatment-refractory schizophrenia: Evidence for a differential impact of clozapine

1997

Journal Article

The cognitive neuropsychology of schizophrenia.

McGrath, J (1997). The cognitive neuropsychology of schizophrenia.. Australian And New Zealand Journal of Psychiatry, 31 (6), 894-895.

The cognitive neuropsychology of schizophrenia.

1997

Journal Article

Development of a screening interview and brief diagnostic interview for psychotic disorders

Castle, DJ, Jablensky, AV, Waterreus, A, McGrath, J, Cardy, S, Herrman, H and Gureje, O (1997). Development of a screening interview and brief diagnostic interview for psychotic disorders. Schizophrenia Research, 24 (1-2), 5-5. doi: 10.1016/S0920-9964(97)82011-7

Development of a screening interview and brief diagnostic interview for psychotic disorders

1997

Journal Article

Performance on tests sensitive to impaired executive ability in schizophrenia, mania and well controls: acute and subacute phases

McGrath, J, Scheldt, S, Welham, J and Clair, A (1997). Performance on tests sensitive to impaired executive ability in schizophrenia, mania and well controls: acute and subacute phases. Schizophrenia Research, 26 (2-3), 127-137. doi: 10.1016/S0920-9964(97)00070-4

Performance on tests sensitive to impaired executive ability in schizophrenia, mania and well controls: acute and subacute phases

1997

Journal Article

Thought disorder and executive ability

McGrath, John, Scheldt, Susan, Hengstberger, Peter and Dark, Frances (1997). Thought disorder and executive ability. Cognitive Neuropsychiatry, 2 (4), 303-314. doi: 10.1080/135468097396306

Thought disorder and executive ability

1997

Journal Article

Schizophrenia.

McGrath, J (1997). Schizophrenia.. Australian And New Zealand Journal of Psychiatry, 31 (6), 894-895.

Schizophrenia.

1996

Journal Article

Pathological laughing and crying

Dark, F. L., McGrath, J. J. and Ron, M. A. (1996). Pathological laughing and crying. Australian and New Zealand Journal of Psychiatry, 30 (4), 472-479. doi: 10.3109/00048679609065020

Pathological laughing and crying

1996

Journal Article

Dermatoglyphic a-b ridge count as a possible marker for developmental disturbance in schizophrenia: Replication in two samples

Fananas, L., van Os, J., Hoyos, C., McGrath, J., Mellor, C. S. and Murray, R. (1996). Dermatoglyphic a-b ridge count as a possible marker for developmental disturbance in schizophrenia: Replication in two samples. Schizophrenia Research, 20 (3), 307-314. doi: 10.1016/0920-9964(95)00013-5

Dermatoglyphic a-b ridge count as a possible marker for developmental disturbance in schizophrenia: Replication in two samples

1996

Journal Article

Formation of pyridinium species of haloperidol in human liver and brain

Eyles, D. W., McGrath, J. J. and Pond, S. M. (1996). Formation of pyridinium species of haloperidol in human liver and brain. Psychopharmacology, 125 (3), 214-219. doi: 10.1007/BF02247331

Formation of pyridinium species of haloperidol in human liver and brain

1996

Journal Article

Evidence and tardive dyskinesia

Soares, Karla, McGrath, John and Adams, Clive (1996). Evidence and tardive dyskinesia. Lancet, 347 (9016), 1696-1697. doi: 10.1016/S0140-6736(96)91525-1

Evidence and tardive dyskinesia

1996

Journal Article

Incorporating lag effects in register-based age-of-onset distributions in schizophrenia

Welham, J. L., Pemberton, M. R. and McGrath, J. J. (1996). Incorporating lag effects in register-based age-of-onset distributions in schizophrenia. Schizophrenia Research, 20 (1-2), 125-132. doi: 10.1016/0920-9964(95)00087-9

Incorporating lag effects in register-based age-of-onset distributions in schizophrenia

1996

Journal Article

Neurogenesis in adult human

Murrell, Wayne, Bushell, Gillian R., Livesey, Jonathon, McGrath, John, MacDonald, Kelli P.A., Bates, Paul R. and Mackay Sim, Alan (1996). Neurogenesis in adult human. NeuroReport, 7 (6), 1189-1194. doi: 10.1097/00001756-199604260-00019

Neurogenesis in adult human

1995

Journal Article

Month of birth, hemisphere of birth and schizophrenia

McGrath, J., Welham, J. and Pemberton, M. (1995). Month of birth, hemisphere of birth and schizophrenia. British Journal of Psychiatry, 167 (06), 783-785. doi: 10.1192/bjp.167.6.783

Month of birth, hemisphere of birth and schizophrenia

1995

Journal Article

Minor physical anomalies in psychoses: Associations with clinical and putative aetiological variables

McGrath, J. J., van Os, J., Hoyos, C., Jones, P. B., Harvey, I. and Murray, R. M. (1995). Minor physical anomalies in psychoses: Associations with clinical and putative aetiological variables. Schizophrenia Research, 18 (1), 9-20. doi: 10.1016/0920-9964(95)00016-X

Minor physical anomalies in psychoses: Associations with clinical and putative aetiological variables

1995

Journal Article

Remoxipride versus thioridazine in the treatment of first episodes of schizophrenia in drug-naive patients: A case for specific, low potency D-2 antagonists

Lambert, T., Keks, N., McGrath, J., Catts, S., Hustig, H., Vaddadi, K., Burrows, G., Varghese, F., George, T., Kerr, K., Johnson, G., Burnett, P., Zorbas, A., Hill, C. and Copolov, D. (1995). Remoxipride versus thioridazine in the treatment of first episodes of schizophrenia in drug-naive patients: A case for specific, low potency D-2 antagonists. Human Psychopharmacology, 10 (6), 455-460. doi: 10.1002/hup.470100604

Remoxipride versus thioridazine in the treatment of first episodes of schizophrenia in drug-naive patients: A case for specific, low potency D-2 antagonists

1995

Journal Article

An open-label study of famotidine as a treatment for schizophrenia

Whiteford, H. A., Stedman, T. J., McGrath, J. J., Welham, J. and Pond, S. (1995). An open-label study of famotidine as a treatment for schizophrenia. Journal of Psychiatry and Neuroscience, 20 (3), 239-240.

An open-label study of famotidine as a treatment for schizophrenia

1995

Journal Article

An open-label study of famotidine as a treatment for schizophrenia

Whiteford, HA, Stedman, TJ, McGrath, JJ, Welham, JL and Pond, S. (1995). An open-label study of famotidine as a treatment for schizophrenia. Journal of Psychiatry and Neuroscience, 20 (3), 239-240.

An open-label study of famotidine as a treatment for schizophrenia

1994

Journal Article

Schizophrenia and the influenza epidemics of 1954, 1957 and 1959: A southern hemisphere study

McGrath, J. J., Pemberton, M. R., Welham, J. L. and Murray, R. M. (1994). Schizophrenia and the influenza epidemics of 1954, 1957 and 1959: A southern hemisphere study. Schizophrenia Research, 14 (1), 1-8. doi: 10.1016/0920-9964(94)90002-7

Schizophrenia and the influenza epidemics of 1954, 1957 and 1959: A southern hemisphere study

1994

Journal Article

Quantitative analysis of two pyridinium metabolites of haloperidol in patients with schizophrenia

Eyles, D. W., McLennan, H. R., Jones, A., McGrath, J. J., Stedman, T. J. and Pond, S. M. (1994). Quantitative analysis of two pyridinium metabolites of haloperidol in patients with schizophrenia. Clinical Pharmacology and Therapeutics, 56 (5), 512-520. doi: 10.1038/clpt.1994.172

Quantitative analysis of two pyridinium metabolites of haloperidol in patients with schizophrenia